I must admit that I was disheartened as I opened the GMO panel report, and my pdf reader told me that it was 2400 pages.  It took a while to open.  The problem is not (just) the challenge to my laziness, but the fact that many of us who might

As mentioned in an earlier post, we have arranged with Anna-Emilia Autio ([email protected]) and Petko Kantchevski ([email protected]) to report on the panel meetings in the Hormones Sanctions cases (DS320 and DS321).  Due to the length of the meetings, it probably doesn't make

The final panel report on the EU-Biotech dispute has just been released. http://www.wto.org/english/news_e/news06_e/291r_e.htm    I found this report politically savvy but legally ambivalent. First, a moratorium, whether de facto or de jure, is a "ban" or a "

Those interested in how WTO law interacts with the rest of international law may know that in 2002 the UN International Law Commission (ILC) set up a Study Group to examine the “fragmentation” of international law.  Well, the final report and conclusions of this Study Group are now published.  In

Here is a call for papers from the Asian Journal of WTO & International Health Law and Policy (which is part of the Asian Center for WTO & International Health Law and Policy, National Taiwan University): http://www.law.ntu.edu.tw/center/wto/05publications.asp?tb_index=40 It&

Congratulations to Ralf Michaels on a very interesting paper examining the relationship between traditional private international law principles and the principle of recognition in European Union law.  Here is the abstract: EU Law as Private International Law? Re-Conceptualising the Country-of-Origin Principle as Vested Rights Theory RALF MICHAELS Duke University -

Today's FT has an editorial complaining about the extraterritorial inspections of Ernst & Young (in London) carried out recently by the Public Company Accounting Oversight Board under Sarbanes-Oxley (SOX).  The FT's point is that this work is duplicative of UK inspection, and imposes additional (and impliedly

The current WTO panel proceedings in the Hormones Sanctions cases (DS320 and DS321) are noteworthy not just for the interesting issues under the SPS Agreement and the DSU, but also because this panel was the first to open its meetings with the parties to the public.  This took place in